Articles

InfraredX TVC Imaging System Clinical Study STEMI

Infraredx Inc. announced the publication of key data supporting the ability of its TVC imaging system to detect lipid core plaque in patients with ST-segment elevation myocardial infarction (STEMI...

Radiation exposure from multidetector computed tomography (CT) has become a pressing public health concern in both lay and medical publications. Implementation of iterative reconstruction offers...

Just when positron emission tomography (PET) appears to be eclipsing single photon emission computed tomography (SPECT) for cardiac imaging, new advances make SPECT more attractive. Both...

Healthcare reform requiring wider access and enterprise sharing of patient images and records are making Web-based cardiology picture archiving and communication systems (PACS) a more attractive...

Finding ways to lower patient radiation dose from both medical imaging and interventional cardiology has become a major trend. However, when vendors start talking dose, it is important to realize...

The first-ever presentation at a medical conference using hologram technology instead of traditional video projection screen took place July 1 at the American Society of Echocardiography’s (ASE)...

Medical Imaging U.S. Healthcare Overtesting New England Journal of Medicine

Big changes are coming to the U.S. healthcare system — some in response to the mounting scrutiny of medical imaging. New task force recommendations, the Choosing Wisely campaign and Affordable...

Researchers have announced the results of a clinical study that shows a key difference in the patient’s baseline heart size and function following transcatheter valve replacement (TAVR) that may...

Philips Healthcare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its AlluraClarity live image guidance system in the United States.

With recent medical device advances have come increasing concerns about the ability of the United States to remain at the forefront of research, especially in light of stringent FDA policies...